Pharmacy & Toxicology expert witnesses

Litigation involving medications, chemical exposures, or substance-related harm almost always requires a witness who can translate complex pharmacological and toxicological science into opinions a judge and jury can evaluate. Attorneys who rely solely on treating physicians for these opinions often find that the treating provider lacks the depth of pharmacokinetic or regulatory knowledge needed to address causation, standard-of-care deviations, or labeling compliance. A dedicated pharmacy or toxicology expert brings a focused methodology that is easier to defend under a Daubert or Frye challenge than an opinion drawn from a generalist's secondary familiarity with the subject.

Pharmacy experts address the conduct of the dispensing chain — from the prescriber's order through the pharmacist's verification and the patient's receipt of the medication. Toxicology experts address what happens once a substance enters the body: absorption, distribution, metabolism, excretion, and the dose-response relationship that links exposure to alleged harm. These are distinct disciplines, and complex cases frequently require both. An attorney who understands which questions belong to each discipline is better positioned to build a coherent expert strategy from the outset.

Dispensing and medication error cases are among the most frequent matters for which pharmacy experts are retained. These involve a pharmacist or pharmacy technician filling a prescription incorrectly — wrong drug, wrong dose, wrong patient, or failure to counsel about a dangerous drug-drug interaction. Standard-of-care opinions in these cases depend on a detailed understanding of pharmacy practice regulations, state board rules, and institutional protocols, all of which a qualified pharmacist expert can address.

Toxic tort and environmental exposure cases are the primary venue for toxicology experts, who provide both general causation opinions (does this class of exposure cause this class of harm in humans?) and specific causation opinions (did this plaintiff's particular exposure cause their particular injury?). Mass tort and class action pharmaceutical cases often require toxicologists to address population-level dose-response data as well as individual plaintiff exposure histories.

Additional case types include: pharmaceutical product liability and failure-to-warn claims; controlled-substance diversion and prescribing misconduct matters; workers' compensation claims arising from occupational chemical exposure; criminal prosecutions involving drug-facilitated crimes, overdose deaths, or DUI/DUID; and insurance defense matters where coverage turns on whether an injury was caused by a toxic substance or a medication event. Compounding pharmacy errors have emerged as a distinct and growing category, requiring experts with specific knowledge of USP standards and state compounding regulations.

Every expert listed in this directory has been reviewed against a defined set of credential and standing criteria before their profile is published. For pharmacy experts, this includes confirmation of an active pharmacist license in the state or states where they practice, review of the relevant state board of pharmacy disciplinary record, and verification of any claimed board certifications against the issuing body's published records. For toxicology experts, certification claims — including DABT, DABFT, and clinical toxicology credentials — are verified through publicly available certification rosters or direct confirmation with the certifying organization.

Federal exclusion database screening is applied to all experts. This includes the OIG List of Excluded Individuals and Entities and the General Services Administration's System for Award Management exclusions list. Any expert with an active exclusion is not listed. Profiles note the date of most recent credential verification, and credentials are subject to periodic re-review. Attorneys should supplement this verification with their own independent diligence, particularly for jurisdiction-specific licensing requirements and for testimony history that the expert has not affirmatively disclosed.

A well-structured engagement begins with a conflict check and a records review. Pharmacy experts will typically want to review the original prescription, the dispensing record, any patient counseling documentation, and the applicable standard-of-care guidelines or board rules in the relevant jurisdiction. Toxicology experts generally need exposure history, medical records documenting the alleged harm, any available biomonitoring or laboratory data, and relevant environmental or industrial hygiene data where applicable.

Once initial records are reviewed, the expert will provide a preliminary oral opinion before committing to a written report. This allows you to assess the strength of the opinion and refine the scope of the engagement before incurring the cost of a formal report. The written report — required under Federal Rule of Civil Procedure 26 for testifying experts in federal matters, and under analogous state rules — should include the expert's opinions, the basis for each opinion, the data or materials relied upon, and a statement of qualifications. A well-prepared expert in these disciplines will produce a report that anticipates the methodology challenges most commonly raised in Daubert motions, including documentation of peer-reviewed support for causal claims and an explicit discussion of how the expert applied their methodology to the specific facts of the case.

Deposition preparation and trial availability should be confirmed early. Pharmacy and toxicology experts who testify regularly will have a prior testimony list ready, a published rate schedule, and familiarity with the conventions of cross-examination in their subject area. Experts who are new to litigation, even if highly credentialed, may require more preparation time and should be selected with that in mind if trial is approaching.

Opinions in these disciplines face gatekeeping scrutiny at several pressure points. For toxicology causation opinions, courts applying FRE 702 and Daubert commonly examine whether the expert has identified a plausible biological mechanism, whether the opinion rests on peer-reviewed epidemiological or toxicological literature, whether the expert has accounted for confounding exposures, and whether the dose experienced by the plaintiff falls within a range associated with the alleged harm in the scientific literature. General causation opinions that rely primarily on animal studies or in vitro data without epidemiological support have been excluded in a range of federal and state toxic tort matters.

For pharmacy standard-of-care opinions, the methodology challenge is somewhat different: courts ask whether the expert has adequately identified the applicable standard, whether their opinion is grounded in recognized professional guidelines or regulatory requirements, and whether they have articulated why the deviation they describe was the proximate cause of harm rather than a technical irregularity without clinical consequence. Retaining an expert who has published in the relevant area, maintains active clinical practice, and can point to authoritative sources for the standard they are applying significantly reduces the risk of exclusion at the admissibility stage.